The assessment was performed using the major adverse cardiac event (MACE)4 composite that includes cardiovascular death, myocardial infarction, stroke, and unstable angina hospitalization
Known primarily for its remarkable tissue-healing properties, this 15-amino-acid peptide derived from human gastric juice has a surprising body of research supporting its use in allergic and anaphylactoid conditions
This distinction is essential: BPC-157 may be useful as a laboratory research tool, but preclinical observations should not be interpreted as evidence of human therapeutic efficacy, clinical safety, optimal dosing, or suitability for any medical, cosmetic, fitness, wellness, or veterinary purpose
The comparison isn't straightforward
Real-world data cited in the paper suggest roughly half of patients discontinue treatment within a year of starting it a rate far higher than the trials, with their closer supervision, capture